Susquehanna Fundamental Investments’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-630
Closed -$306K 1464
2021
Q3
$306K Buy
+630
New +$306K 0.01% 1403